Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/16/2002CN1375005A Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism
10/16/2002CN1374970A Signal sequence for the productino of leu-hirudine via secretion by E coli in a culture medium
10/16/2002CN1374871A FC fusion proteins for enhancing the immunogenicity of protein and piptide antigens
10/16/2002CN1374869A Use of CASB 616 polypeptides and polynucleotides for cancer treatment
10/16/2002CN1374325A Giant-web bombinator antimicrobial peptide and its prepn and gene
10/16/2002CN1374324A Giant-web bombinator angiectasis factor and its prepn and gene
10/16/2002CN1374323A Giant-web bombinator antineoplastic protein and its prepn and gene
10/16/2002CN1374322A Wide-spectrum antifungal polypeptide LHAFP from motherwort and its purification process
10/16/2002CN1374318A Natural dissociation essence gamma gene and antineoplastic active polypeptide dissociation essence-gamma
10/16/2002CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/15/2002US6466874 A computational method system, and computer program are provided for inferring functional links from genome sequences.
10/15/2002US6465719 Concerns a chimeric gene containing a dna sequence coding for drosomycin, a vector containing the chimeric gene, a method for transforming plants and the resulting transformed plants. the drosomycin produced by the plants provides disease
10/15/2002US6465718 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
10/15/2002US6465716 Nucleotide sequences associated with nodules in plants; for use in regenerating exhausted soils
10/15/2002US6465715 Dna fragments from the promoter region of the c. elegans ul6 gene which are capable of functioning as promoters directing gene expression in the excretory cell of c. elegans are provided and also expression vectors and transgenic c. elegans
10/15/2002US6465635 Promoter sequence of 3-phosphoglycerate kinase gene 1 of lactic acid-producing fungus rhizopus oryzae and a method of expressing a gene of interest in fungal species
10/15/2002US6465634 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
10/15/2002US6465633 Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
10/15/2002US6465632 Human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
10/15/2002US6465630 Isolated nucleic acid encoding a dihydroflavanol 4-reductase that selectively catalyzes the reduction of dihydrokaempferol to leucopelargonidin in the presence of dihydroquercetin and dihydromyricetin comprising a nucleic acid sequence,
10/15/2002US6465627 DAX-1 protein, methods for production and use thereof
10/15/2002US6465624 Purification of von-Willebrand factor by cation exchanger chromatography
10/15/2002US6465623 GDU, a novel signalling protein
10/15/2002US6465622 Having inhibitory activity on the protease activity of hepatocyte growth factor activator
10/15/2002US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002US6465620 Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides
10/15/2002US6465619 Given amino acid sequence; use drug screening for treatment of diseases associated with cell proliferation, such as cancer and autoimmune diseases
10/15/2002US6465617 Polypeptide encoded by cell death-protective gene from the nematode caenorhabditis elegans, called ced-9
10/15/2002US6465616 Modified and variant forms of interleukin-5 having specified amino acid subsitutions
10/15/2002US6465614 High-affinity response-selective C-terminal analogs of C5a anaphylatoxin
10/15/2002US6465613 Administering a somatostatin derivative to a patient for selectively targeting and arresting the growth of an angiogenic blood vessel or a cell
10/15/2002US6465611 Compounds for immunotherapy of prostate cancer and methods for their use
10/15/2002US6465438 Nucleic acid vaccination for parvoviral infections
10/15/2002US6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
10/15/2002US6465432 Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
10/15/2002US6465431 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
10/15/2002US6465430 Treating hematological disorders, particularly thrombo-cytopenia resulting from chemotherapy, radiation therapy or bone marrow transfusions; accelerating blood platelet regeneration
10/15/2002US6465429 Antimicrobial cationic peptides
10/15/2002US6465427 Compounds and methods for modulating cell adhesion
10/15/2002US6465426 Acylation
10/15/2002US6465423 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/15/2002US6465422 Method for inhibiting tumor invasion or spreading in a subject
10/15/2002US6465253 Vectors and methods for gene transfer to cells
10/15/2002US6465246 Oncogene- or virus-controlled expression systems
10/15/2002US6465239 Genetically engineered chromosomes in germ cells; high protein and muscle foods
10/15/2002US6465216 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein
10/15/2002US6465214 Antithrombin protein and DNA sequences from black fly
10/15/2002US6465213 Nucleotide sequences
10/15/2002US6465212 Leukotriene receptor
10/15/2002US6465211 Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides
10/15/2002US6465210 Nucleic acid molecules encoding CASPR/p190
10/15/2002US6465200 Transcription factor regulatory protein
10/15/2002US6465198 Essential fungal genes and their use
10/15/2002US6465188 Nucleic acid ligand complexes
10/15/2002US6465184 Determining gene expression of nucleic acid encoding tumor rejection antigen precursors
10/15/2002US6465181 Reagents and methods useful for detecting diseases of the prostate
10/15/2002US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/15/2002US6464998 Composition for the in vivo production of therapeutic products
10/15/2002US6464985 Ospc dra fragment fusion peptide isolated from borrelia burgdorferi
10/15/2002US6464984 Avian polynucleotide vaccine formula
10/15/2002US6464983 Methods and uses of connective tissue growth factor for differentiation of mesenchymal stem cells
10/15/2002US6464980 MAGE-1 c-terminal immunogenic peptides
10/15/2002US6464979 Chlamydial vaccines and methods of preparation thereof
10/15/2002US6464978 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
10/15/2002US6464975 Heparin-binding glycoprotein-related peptide; facilitates angiogenesis or wound healing
10/15/2002US6464974 Immunosuppressant target proteins
10/15/2002CA2261964C New tumor suppressor gene and the protein coded thereby, methods of production and use thereof
10/15/2002CA2169173C Methods for stimulating erythropoiesis using thrombopoietin
10/15/2002CA2106675C Enzymatic process for the preparation of macrolactone
10/15/2002CA2105172C Fused genes and their use for determining the presence of metals or of xenobiotic compounds
10/15/2002CA2091873C Parathyroid hormone derivatives
10/15/2002CA2071912C Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
10/10/2002WO2002079784A1 G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model
10/10/2002WO2002079756A2 Novel molecules of the multi-drug and toxin efflux (mate) protein family and uses thereof
10/10/2002WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002WO2002079500A1 METHODS OF IDENTIFYING AGENT THAT AFFECT CLEAVAGE OF AMYLOID-β PRECURSOR PROTEIN
10/10/2002WO2002079494A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002WO2002079492A2 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079476A1 Method of detecting the expression of aspergillus gene
10/10/2002WO2002079475A2 Streptococcus pyogenes antigens and corresponding dna fragments
10/10/2002WO2002079474A2 Human b7 polypeptides
10/10/2002WO2002079473A2 Molecules for diagnostics and therapeutics
10/10/2002WO2002079472A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079471A2 Cholinesterase-anchoring protein, corresponding nucleic acids and their use for preparing medicines
10/10/2002WO2002079465A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/10/2002WO2002079463A2 Methods for modification of plant inflorescence architecture
10/10/2002WO2002079457A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002WO2002079450A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/10/2002WO2002079449A2 Molecules for disease detection and treatment
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079447A2 Avian lysozyme promoter
10/10/2002WO2002079446A2 Transgenic mice containing gpr31 gene disruptions
10/10/2002WO2002079443A2 Transgenic mice containing 5-ht5b serotonin receptor gene disruptions
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079439A2 TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS
10/10/2002WO2002079437A2 Transgenic mice containing abc transporter-like aptase gene disruptions
10/10/2002WO2002079435A2 Transgenic mice containing gpcr-like gene disruptions
10/10/2002WO2002079434A2 Transgenic mice containing kir3.3 potassium channel gene disruptions
10/10/2002WO2002079432A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
1 ... 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 ... 2916